Commercial IT's role in biopharma continues to evolve. While historically most teams have built their commercial tech stacks around enabling HCP engagement and Sales workflows, with the explosion of specialty medicines and rise of internal patient support services, the mandate is shifting. Today, they're tasked with doing more than ever before, jumping between supporting business needs (including the rise of internal Patient Services & Field Access), contending with data and tech sprawl, and staying on top of AI advancements.

After diagnosis and prescription, a patient enters a long and complex process to start and stay on a specialty medicine that some commercial IT teams have never had to support internally. It involves lengthy enrollment forms, benefits investigation, prior authorization and appeals, Specialty Pharmacy (SP) coordination, copay activation, and adherence support. Each step brings its own internal and external stakeholders, data sources, workflows and requirements, and failure points.

For Commercial IT leaders, understanding what happens at each stage is the first step towards partnering with the Business and building the right infrastructure to support effective patient journey management.

"It's not enough to know technology and digital solutions, you need to understand the business space that you operate in extremely well." - Andrew Schwartz, VP & Global Head of IT

What’s more, this trend towards internal ownership of the patient experience is only accelerating. According to the 2026 State of Patient-Centricity in Biopharma, 83% of manufacturers now manage Field Access and Reimbursement internally, and 54% manage Patient Services internally. As programs move in-house, the systems and integrations required to run them fall on IT, and the infrastructure decisions made today will define what's possible tomorrow.

Are Your Systems Built for Patient Access?

Specialty patient access requires data from HUB services providers, SP networks, payer systems, copay vendors, and data aggregators, each with different formats, timeliness, and varying levels of quality and completeness.

Each stage of the patient journey involves multiple micro-steps and processes, involving different stakeholders, powered by different data sources, and susceptible to its own operational challenges. Patient access is nonlinear and dynamic; in practice, each path to start and stay on therapy looks more like a messy, interconnected web with loops backwards and jumps forward depending on what happens than the linear assumption.

"The specialty patient journey is much more like a customer service and case management journey than a sales and marketing journey… A sales rep walks into a provider’s office and changes minds. A Field Reimbursement Manager walks in and fixes things." - Head of Digital, and Technology, Top 20 Pharma

This complexity starts at the front door. Whether a HUB is internal or external, fax remains the dominant intake channel for patient enrollment forms.

A wrong insurance ID entered during intake may seem like a small mistake, but its impact often isn't felt until much later, surfacing as a benefits verification failure or even a prior authorization denial weeks down the line. By then, the issue is several steps removed from its source, and because intake typically lives with the HUB, the clean-up often lands on Commercial IT.

BI/BV is another example of how quickly that complexity compounds. Completing just one BV can require coordination across multiple channels and stakeholders, spanning everything from manual outreach to voice AI calls to eBV. Case workers navigate this complexity every day, and the systems supporting them should be built for it. This leaves IT leaders with a choice: become experts in architecting this ecosystem — dynamic sequencing and all — or partner with someone who already has.

If you’re steeped in the world of specialty biopharma, none of this is news, but it's meant to illustrate a bigger point: the operational complexity packed into a single stage of the patient journey. BV is one example among many that add up to the enormous data challenge facing Commercial IT and Business partners. It's why investing in the right patient access is so important: every stage generates data another stage depends on.

The Patient-Centered Commercial IT Leader

Building the next generation of patient-centered infrastructure requires the IT and Business counterparts building together from the start. That kind of partnership requires more than technical fluency. It means understanding Patient Services and Field Access deeply: how it works, where pain points and friction are experienced, and what outcomes are trying to be achieved.

“If your approach is to map out business requirements and then bring technology into the mix, you're missing an opportunity. You need to co-create with technology at the table, focused on the outcomes you want to drive” - Andres Diaz, Head of Product Management & Portfolio (Technology)

The partnership doesn't just lead to better technology decisions, it also creates the foundation for meaningful AI. The most successful teams start with a deep understanding of their data, workflows, and the outcomes they want to improve.

"There are a lot of tasks that require more human effort than they should. Technology is an accelerant to help people focus on creative thinking, human empathy, and navigating complex organizations." - Danny Sigurdson, Founder and CEO, Courier Health

As the lines between people, process, and technology are blurring, the real innovators aren't just connecting technology decisions to business requirements, they're connecting them to patient outcomes.

That's the mindset shift we explore in "The Commercial IT Leader's Guide to Patient Access," including the key considerations to make when evaluating new solutions. Download it here.